CN105232564A - D-核糖用于改善心肺功能的用途 - Google Patents

D-核糖用于改善心肺功能的用途 Download PDF

Info

Publication number
CN105232564A
CN105232564A CN201510527242.0A CN201510527242A CN105232564A CN 105232564 A CN105232564 A CN 105232564A CN 201510527242 A CN201510527242 A CN 201510527242A CN 105232564 A CN105232564 A CN 105232564A
Authority
CN
China
Prior art keywords
ribose
effective dose
life
gram
fatigue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510527242.0A
Other languages
English (en)
Chinese (zh)
Inventor
J.A.圣塞尔
D.J.麦卡特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioenergy Inc
Original Assignee
Bioenergy Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioenergy Inc filed Critical Bioenergy Inc
Publication of CN105232564A publication Critical patent/CN105232564A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Medicinal Preparation (AREA)
CN201510527242.0A 2008-08-20 2009-08-20 D-核糖用于改善心肺功能的用途 Pending CN105232564A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US18949808P 2008-08-20 2008-08-20
US61/189498 2008-08-20
US20812209P 2009-02-20 2009-02-20
US61/208122 2009-02-20
CN2009801324503A CN102215846A (zh) 2008-08-20 2009-08-20 D-核糖用于疲劳对象的用途
PCT/US2009/004738 WO2010021713A1 (en) 2008-08-20 2009-08-20 Use of d-ribose for fatigued subjects

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2009801324503A Division CN102215846A (zh) 2008-08-20 2009-08-20 D-核糖用于疲劳对象的用途

Publications (1)

Publication Number Publication Date
CN105232564A true CN105232564A (zh) 2016-01-13

Family

ID=41172394

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201510527242.0A Pending CN105232564A (zh) 2008-08-20 2009-08-20 D-核糖用于改善心肺功能的用途
CN2009801324503A Pending CN102215846A (zh) 2008-08-20 2009-08-20 D-核糖用于疲劳对象的用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2009801324503A Pending CN102215846A (zh) 2008-08-20 2009-08-20 D-核糖用于疲劳对象的用途

Country Status (8)

Country Link
US (2) US20100189785A1 (enExample)
EP (1) EP2323668A1 (enExample)
JP (2) JP2012500261A (enExample)
CN (2) CN105232564A (enExample)
AU (1) AU2009283215B2 (enExample)
BR (1) BRPI0917360A2 (enExample)
CA (1) CA2734769A1 (enExample)
WO (1) WO2010021713A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009123742A1 (en) * 2008-04-02 2009-10-08 St Cyr John A Use of ribose in first response to acute myocardial infarction
CN102488669A (zh) * 2011-12-30 2012-06-13 上海希迪制药有限公司 一种改善d-核糖引湿性的方法
CN115708831A (zh) * 2014-11-03 2023-02-24 生物能量生命科学有限公司 使用d-核糖增强对躯体应激的适应性
WO2017120731A1 (en) * 2016-01-11 2017-07-20 Shanghai Yao Yuan Biotechnology Co., Ltd. Methods and compositions for reducing body weight
JP6542687B2 (ja) 2016-01-28 2019-07-10 日本特殊陶業株式会社 ガスセンサユニット
US10434113B2 (en) 2016-12-16 2019-10-08 The Charlotte Mecklenburg Hospital Authority Compositions and methods for treating muscular dystrophy and other disorders
WO2019200132A1 (en) * 2018-04-12 2019-10-17 Metabolic Recovery Systems, LLC Compositions and methods for supplementing the diet
US20200061092A1 (en) * 2018-08-24 2020-02-27 The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health Methods and compositions for treating disorders associated with muscle weakness
KR102435548B1 (ko) * 2022-05-31 2022-08-26 (주)에이피테크놀로지 액상스틱형 에너지 스포츠 음료

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306431A (zh) * 1998-06-19 2001-08-01 生物能公司 用于增加体内能量的组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228215A1 (de) * 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
EP1745789A1 (en) * 1998-06-19 2007-01-24 Bioenergy Inc. Compositions comprising ribose for increasing energy in vivo
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
CA2325033C (en) * 1999-10-27 2007-05-22 Bioenergy Inc. Use of ribose to treat fibromyalgia
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US6855727B2 (en) * 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
JP4754484B2 (ja) * 2004-03-18 2011-08-24 田辺三菱製薬株式会社 うつ様症状改善剤
WO2005107768A2 (en) * 2004-04-29 2005-11-17 Bioenergy, Inc. Method for improving ventilatory efficiency
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
US7645742B2 (en) * 2005-06-22 2010-01-12 Advocare International, L.P. Composition for enhancing cellular energy
US11861305B2 (en) 2020-12-07 2024-01-02 Hitachi, Ltd. Word processing system and word processing method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306431A (zh) * 1998-06-19 2001-08-01 生物能公司 用于增加体内能量的组合物

Also Published As

Publication number Publication date
JP2012500261A (ja) 2012-01-05
WO2010021713A1 (en) 2010-02-25
US20120264701A1 (en) 2012-10-18
BRPI0917360A2 (pt) 2015-11-17
JP2016014009A (ja) 2016-01-28
AU2009283215A2 (en) 2011-05-12
US20100189785A1 (en) 2010-07-29
CN102215846A (zh) 2011-10-12
AU2009283215B2 (en) 2014-12-04
CA2734769A1 (en) 2010-02-25
AU2009283215A1 (en) 2010-02-25
EP2323668A1 (en) 2011-05-25

Similar Documents

Publication Publication Date Title
CN105232564A (zh) D-核糖用于改善心肺功能的用途
LeMura et al. Lipid and lipoprotein profiles, cardiovascular fitness, body composition, and diet during and after resistance, aerobic and combination training in young women
Brown et al. Exercise physiology: basis of human movement in health and disease
Sell et al. Energy expenditure during physically interactive video game playing in male college students with different playing experience
Staten et al. Provider counseling, health education, and community health workers: the Arizona WISEWOMAN project
Smith et al. A pilot study to examine the impact of beta-alanine supplementation on anaerobic exercise performance in collegiate rugby athletes
JP2016516418A (ja) トリソミー２１、自閉症スペクトラム障害および／または多動性を伴うまたは伴わない注意欠陥障害の人のための食品補助剤
Allison et al. Treatment and prevention of obesity: what works, what doesn’t work, and what might work
Papale et al. The Impact of a Multidimensional Physical Activity Intervention on Glycemic Control in Type 1 Diabetes: A Preliminary Study
Block et al. The work and home activities questionnaire: energy expenditure estimates and association with percent body fat
Gobbi et al. Low-intensity whole-body vibration: a useful adjuvant in managing obesity? A pilot study
US20160317561A1 (en) Use of d-ribose for fatigued subjects
Quaresma et al. Clinical practice guidelines for sports nutrition: brazilian sports nutrition association
Rahimi Quantification of the anaerobic contribution during low to moderate intensity exercise with different fluctuation amplitudes
Mugrage The Effects of Chronic vs Acute Sodium Bicarbonate Loading on Run Time to Exhaustion in Endurance Athletes
Barry An assessment of obesity through lifestyle self-monitoring and cardiorespiratory fitness
Smith The effect of functional resistance training on the resting metabolic rate of apparently healthy adult women
Harvey et al. EFFECTS OF THE CURVES™ FITNESS & WEIGHT LOSS PROGRAM I: BODY COMPOSITION
Ekwerekwu Collegiate football student-athlete body mass composition change related to mandatory breakfast consumption
Werner The Effect of High-Carbohydrate, Low-Fat & Low-Carbohydrate, High Protein Diets on Physiologic and Performance Variables on Row Ergometry Training
Nisman THE EFFECT OF DIET AND EXERCISE
Oosthuizen An evaluation of the mental skills, nutritional preferences and anthropometric characteristics of the pro junior under 20 surfers in the 2008 Billabong Junior Series in South Africa
Derosier The effects of varying postexercise nutrition on subsequent exercise performance in active adults habitually consuming a low-carbohydrate/high-fat diet
Lara Effects of exercise and a thirty-six hour fast on resting metabolic rate and substrate utilization
Keadle The influence of free-living activity and inactivity on health outcomes and responsiveness to exercise training

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20160113

RJ01 Rejection of invention patent application after publication